Clinical Value of Combined Detection of CK-MB, MYO, Ctni and Plasma NT-proBNP in the Diagnosis of Acute Myocardial Infarction
LIU Huan,LI Yan,XU Shu-wen,DAI Wen
DOI: https://doi.org/10.3969/j.issn.1003-6350.2015.23.1266
2015-01-01
Abstract:Objective To study the changes in the level of creatine kinase isoenzyme-MB (CK-MB), myohe-moglobin (MYO), cardiac troponin I (cTnI) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with acute myocardial infarction (AMI), and to evaluate the clinical value of joint detection for the diagnosis of AMI. Methods Plasma NT-proBNP, CK-MB, MYO and cTnI were detected by chemiluminescence immunoassay (CLIA) in 208 patients with AMI (AMI group) and 115 patients without AMI (control group). SPSS19.0 was used to analyze the results. Results The concentrations of CK-MB, MYO, cTnI and NT-proBNP in AMI group were significantly higher than those in the control group (P<0.05). In AMI group, a significantly positive correlation was found between CK-MB and each of MYO and cTnI (r=0.537, r=0.226). The individual sensitivity of CK-MB, MYO, cTnI and NT-proBNP were 75.00%, 84.62%, 79.82% and 86.06%, and the specificity were 81.74%, 69.57%, 94.78% and 84.35%. The sensitivity of combined detection of CK-MB and MYO, CK-MB and cTnI, MYO and cTnI were 86.06%, 82.21%and 85.58%, and the specificity were 65.22%, 77.39%and 67.83%. The sensitivity of combined detection of CK-MB, MYO and cTnI was 87.50%, and the specificity was 63.48%. The sensitivity of combined detection CK-MB, MYO, cTnI and NT-proBNP reached 92.79%, and the specificity was 69.57%. Conclusion Joint detection of CK-MB, MYO, cTnI plasma NT-proBNP levels will contribute significantly to the early diagnosis of AMI. It can also supply di-agnostic evidence to clinic and lower the mortality of AMI in acute phase.